Freskaro refresh & revitalize Magnesium Citrate Saline Laxative Oral… — Class II drug recall D-0231-2024
Ongoing recall by Pharma Nobis LLC, reported 2024-01-24, distributed nationwide. MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.
| Recall number | D-0231-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pharma Nobis LLC, Texarkana, TX, United States |
| Recall initiated | 2023-12-21 |
| Classified | 2024-01-12 |
| Reported by FDA | 2024-01-24 |
| Distributed | Nationwide (US) |
| Quantity | 7,404 bottles |
| Reason classes | microbial contamination, sterility |
| NDC | 82645-0312, 82645-0312-10 |
| Lot numbers | A80622 |
| Expiration dates | 2025-11 |
Product
Freskaro refresh & revitalize Magnesium Citrate Saline Laxative Oral Solution Cherry Flavor 10 fl. oz, Manufactured by: Pharma Lobis, 7400 Alumax Dr., Texarkana, TX 75501, NDC 82645-312-10.
Reason for recall
MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0231-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.